Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Kåberg

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Hepatitis C elimination - Macro-eliminationMartin Kåberg, Ola Weiland
The Lancet. Gastroenterology & Hepatology|September 25, 2018
HCV treatment for people with recent drug use: time for new measures of success?Anne Øvrehus, Martin Kåberg
Substance Abuse Treatment, Prevention, and Policy|April 22, 2023
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversalsElin Holmén, Anna Warnqvist, Martin Kåberg
Infectious Diseases (London, England)|June 3, 2017
Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange programMartin Kåberg, Anders Hammarberg, Christer Lidman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 22, 2022
Quality-adjusted life years among people who inject drugs in a needle syringe program in SwedenMartin Kåberg, Sofie Larsson, Jakob Bergström, et al.
BMC Psychiatry|December 8, 2022
Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?Jakob Svensson, Johan Bergström, Martin Kåberg, et al.
Scandinavian Journal of Gastroenterology|March 26, 2019
Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticityMartin Kåberg, Erika Edgren, Anders Hammarberg, et al.
Journal of Viral Hepatitis|July 13, 2018
Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV eliminationMartin Kåberg, Georg Navér, Anders Hammarberg, et al.
BMC Psychiatry|March 28, 2025
Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of carePer-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
BMC Psychiatry|August 1, 2025
Correction: Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of carePer-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Liver International : Official Journal of the International Association for the Study of the Liver|February 21, 2020
Hepatitis C elimination - Macro-eliminationMartin Kåberg, Ola Weiland
The Lancet. Gastroenterology & Hepatology|September 25, 2018
HCV treatment for people with recent drug use: time for new measures of success?Anne Øvrehus, Martin Kåberg
Substance Abuse Treatment, Prevention, and Policy|April 22, 2023
Sweden's first Take-Home Naloxone program: participant characteristics, dose endpoints and predictors for overdose reversalsElin Holmén, Anna Warnqvist, Martin Kåberg
Infectious Diseases (London, England)|June 3, 2017
Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange programMartin Kåberg, Anders Hammarberg, Christer Lidman, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 22, 2022
Quality-adjusted life years among people who inject drugs in a needle syringe program in SwedenMartin Kåberg, Sofie Larsson, Jakob Bergström, et al.
BMC Psychiatry|December 8, 2022
Patterns of mortality risk among patients with substance use disorder: an opportunity for proactive patient safety?Jakob Svensson, Johan Bergström, Martin Kåberg, et al.
Scandinavian Journal of Gastroenterology|March 26, 2019
Hepatitis C virus (HCV) related liver fibrosis in people who inject drugs (PWID) at the Stockholm Needle Exchange - evaluated with liver elasticityMartin Kåberg, Erika Edgren, Anders Hammarberg, et al.
Journal of Viral Hepatitis|July 13, 2018
Incidence and spontaneous clearance of hepatitis C virus (HCV) in people who inject drugs at the Stockholm Needle Exchange-Importance for HCV eliminationMartin Kåberg, Georg Navér, Anders Hammarberg, et al.
BMC Psychiatry|March 28, 2025
Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of carePer-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
BMC Psychiatry|August 1, 2025
Correction: Psychiatrist-led hepatitis C (HCV) treatment at an opioid agonist treatment clinic in Stockholm- a model to enhance the HCV continuum of carePer-Erik Klasa, Mikael Sandell, Soo Aleman, et al.
Pageof 4